Angiotensin‐Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC‐QIC Registry

BACKGROUND: The routine use of angiotensin‐converting enzyme inhibitors (ACEI) during palliation of hypoplastic left heart syndrome is controversial. We sought to describe ACEI prescription in the interstage between stage 1 palliation (stage I Norwood procedure) discharge and stage 2 palliation (sta...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Hansen, Jesse E., Brown, David W., Hanke, Samuel P., Bates, Katherine E., Tweddell, James S., Hill, Garick, Anderson, Jeffrey B.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7660880/
https://ncbi.nlm.nih.gov/pubmed/32384002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.014823
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars